Medicines for malaria, tuberculosis, and AIDS are all available for children, but none are formulated specifically for the younger patient population. Recently, the World Health Organization generated an essential drug list for kids. How will they follow up on this effort? Dr. Stephen M. Spielberg, professor of pediatrics, pharmacology and toxicology at Dartmouth Medical School, and principal investigator for the Institute for Pediatric Innovation's Pediatric Pharmaceutical Reformulation Project, joins host Dr. Bill Rutenberg to discuss some of the challenges ahead: formulation, dosing, preservation, delivery and beyond.
Worldwide Challenge: Formulating Drugs for Children
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Medicines for malaria, tuberculosis, and AIDS are all available for children, but none are formulated specifically for the younger patient population. Recently, the World Health Organization generated an essential drug list for kids. How will they follow up on this effort? Dr. Stephen M. Spielberg, professor of pediatrics, pharmacology and toxicology at Dartmouth Medical School, and principal investigator for the Institute for Pediatric Innovation's Pediatric Pharmaceutical Reformulation Project, joins host Dr. Bill Rutenberg to discuss some of the challenges ahead: formulation, dosing, preservation, delivery and beyond.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
0.50 credits
<p>IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue</p>
CME/CE
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
0.25 credits
<p>IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy</p>
CME/CE
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
1.00 credits
<p>Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
CME/CE
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
1.00 credits
<p>Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers</p>
CME/CE
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
<p>FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure</p>
MinuteCE®
Second-line Chemotherapy Options in Metastatic PDAC
0.25 credits
<p>Second-line Chemotherapy Options in Metastatic PDAC</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?